A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats

BACKGROUND: Non‐replicating respiratory syncytial virus (RSV) vaccine candidates could potentially prime for enhanced respiratory disease (ERD) due to a T‐cell‐mediated immunopathology, following RSV infection. Vaccines with built‐in immune response modifiers, such as Toll‐like receptor (TLR) ligand...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamphuis, Tobias, Stegmann, Toon, Meijerhof, Tjarko, Wilschut, Jan, de Haan, Aalzen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2013
Materias:
Part 3
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634254/
https://www.ncbi.nlm.nih.gov/pubmed/23575113
http://dx.doi.org/10.1111/irv.12112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634254/
https://www.ncbi.nlm.nih.gov/pubmed/23575113
http://dx.doi.org/10.1111/irv.12112

Ejemplares similares